Pharmaceutical companies manufacture drugs that are used in medicines to cure illness ranging from cancer to a common cold. India has some of the world's largest pharmaceutical companies who have a strong reputation for mass producing generic drugs.
Name | Price | M Cap | Analyst Rating | Target Price | Alpha | 1Y Return | 3Y Return | 5Y Return | PE | Industry PE | PB | Beta | Div Yld | Net Profit Qtr | Net Profit QoQ % | Net Profit YoY % | Net Profit 3Y Change % | Rev Qtr (in Cr) | Rev QoQ (in %) | Rev 1Y change % | Rev 3Y change % | Profit Mar Qtr | Profit Mar QoQ | Profit Mar 1Y Change% | Profit Mar 3Y Change% | Sector | M Cap | ROE | ROCE | EPS | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd | ₹1,818.00 | Large Cap | BUY | 2043.32 | 28.37% | 52.01% | 122.52% | 335.58% | 38.93 | 56.74 | 16.41 | 0.45 | 0.83% | 3030.67 Cr | 5.55% | 12.7% | 322.31% | 13264.22 | 5.91% | 10.51% | 44.77% | 19.89% | 1.99% | 191.7% | Basic Materials | 430584.65 | 12.05% | 12.22% | 40.21 | 1069649 | |
Divis Laboratories Ltd | ₹5,895.15 | Large Cap | HOLD | 4668.46 | 44.12% | 67.76% | 21.8% | 252.76% | 85.32 | 56.74 | 6.75 | 0.47 | 0.87% | 510 Cr | 18.6% | 2338 | 10.39% | 1% | 12.56% | 20.4% | 7.44% | Basic Materials | 156625.13 | 12.04% | 16.27% | 60.38 | 1339441 | ||||
Cipla Ltd | ₹1,541.30 | Large Cap | BUY | 1627.08 | 1.19% | 24.83% | 69.53% | 246.68% | 28.02 | 56.74 | 4.31 | 0.2 | 0.87% | 1306.02 Cr | 11.03% | 46.55% | 73.04% | 6961.22 | 5.08% | 13.28% | 34.52% | 16.12% | 5.66% | 29.37% | 28.64% | Basic Materials | 125403.42 | 15.5% | 20.1% | 51.47 | 1725382 |
Dr Reddys Laboratories Ltd | ₹1,276.40 | Large Cap | HOLD | 1336.87 | 18.16% | 32.96% | 133.05% | 20.09 | 56.74 | 4.22 | 0.4 | 0.65% | 1341.9 Cr | 23.75% | 185.81% | 8016.1 | 4.48% | 13.54% | 47.06% | 19.91% | 8.99% | 94.35% | Basic Materials | 107460.41 | 19.42% | 25.4% | 66.88 | 1175591 | |||
Torrent Pharmaceuticals Ltd | ₹3,168.95 | Large Cap | BUY | 3596.55 | 29.06% | 52.7% | 125.81% | 255.62% | 59.19 | 56.74 | 12.89 | 0.31 | 1.08% | 453 Cr | 33.02% | 32.31% | 2831 | 0.57% | 11.51% | 34.02% | 15.44% | 19.28% | Basic Materials | 106661.37 | 20.43% | 20.4% | 48.94 | 172047 | |||
Mankind Pharma Ltd | ₹2,671.80 | Large Cap | BUY | 2814.88 | 20.43% | 44.07% | 86.08% | 86.08% | 50.14 | 56.74 | 9.56 | 0.3 | NA | 658.88 Cr | 21.33% | 48.26% | 50.17% | 3076.51 | 6.33% | 18.12% | 66.3% | 18.79% | 14.1% | 25.52% | Pharmaceuticals | 106036.48 | 20.95% | 25.77% | 48.47 | 272157 | |
Zydus Lifesciences Ltd | ₹953.65 | Large Cap | HOLD | 1168.69 | 31.61% | 55.25% | 96.46% | 330.59% | 23.31 | 56.74 | 6.43 | 0.58 | 0.3% | 1463.6 Cr | 19.09% | 92.98% | 80.31% | 6046.5 | 12.67% | 13.4% | 35.71% | 19.72% | 5.69% | 70.18% | 32.86% | Basic Materials | 97378.29 | 23.45% | 22.73% | 38.31 | 874885 |
Lupin Ltd | ₹2,108.00 | Mid Cap | HOLD | 2118.36 | 53.2% | 76.84% | 119.87% | 185.47% | 36.17 | 56.74 | 3.58 | 0.34 | 0.49% | 859.48 Cr | 6.7% | 332.35% | 57.63% | 5497.01 | 20.25% | 31.97% | 9.67% | 7.03% | 259.55% | 19.44% | Basic Materials | 95112.08 | 11.92% | 13.96% | 42.47 | 1335431 | |
Aurobindo Pharma Ltd | ₹1,279.65 | Mid Cap | BUY | 1591.15 | 7.98% | 31.62% | 87.39% | 197.12% | 21.05 | 56.74 | 3.24 | 0.55 | 0.41% | 816.95 Cr | 64.4% | 7646.21 | 2.53% | 16.68% | 17.06% | 10.93% | 40.89% | Basic Materials | 75530.42 | 10.35% | 11.74% | 54.09 | 3249749 | ||||
Alkem Laboratories Ltd | ₹5,557.90 | Mid Cap | HOLD | 5721.9 | 6.66% | 30.3% | 58.41% | 172.24% | 32.73 | 56.74 | 5.6 | 0.51 | 0.81% | 550.24 Cr | 80.71% | 79.92% | 11.97% | 3031.82 | 3.27% | 9.21% | 42.89% | 14.3% | 74.99% | 64.75% | Basic Materials | 67241.56 | 17.56% | 17.28% | 151.52 | 266763 | |
Abbott India Ltd | ₹29,030.90 | Mid Cap | BUY | 27192.17 | 20.61% | 45.41% | 143.54% | 0 | 56.74 | 15.48 | 0.44 | NA | 0 Cr | 0% | 16.35% | 0% | NA | 0% | 14.52% | 0% | 14.18% | 0% | 1.6% | 0% | Basic Materials | 61039.14 | 34.88% | 44.71% | 35.67 | 7021 | |
Glenmark Pharmaceuticals Ltd | ₹1,612.85 | Mid Cap | BUY | 1563.43 | 90.58% | 114.22% | 211.99% | 494.69% | -35.17 | 56.74 | 1.18 | 0.87 | 0.26% | 340.24 Cr | 3223.3 | 6.87% | 1.98% | 7.94% | Basic Materials | 46115.19 | 6.98% | 9.75% | 445606 |
Innovation and Breakthroughs
Pharma stocks offer exposure to companies at the forefront of medical innovation, driving breakthrough treatments and advancements.
Global Health Trends
Investing in pharma stocks aligns with addressing global health challenges, positioning these stocks for sustained long-term growth.
Regulatory Stability
Pharma stocks demonstrate resilience to regulatory changes, providing a stable investment environment for investors seeking predictability in the sector.
Regulatory Environment
Assess the regulatory landscape affecting pharma stocks to understand potential impacts on operations and financials.
Pipeline of Innovation
Examine the innovation pipeline of pharma companies, assessing their potential for developing new drugs and medical technologies.
Financial Health
Thoroughly analyze the financial health of healthcare companies, considering factors like revenue growth, profitability, and debt levels.
Demographic Trends:
Consider demographic trends and their influence on healthcare needs, as an aging population often leads to increased demand for medical services.
Competition and Market Position
Evaluate the competitive landscape and market positioning of pharma stocks to identify companies with a strong foothold in the industry
Global Health Issues
Stay informed about global health issues, as they can significantly impact the demand for healthcare services and pharmaceuticals, influencing the performance of pharma stocks.
Name | Price | M Cap | Alpha | 1Y Return | 3Y Return | 5Y Return | PE | Industry PE | PB | Beta | Net Profit Qtr | Net Profit QoQ % | Net Profit YoY % | Net Profit 3Y Change % | Rev Qtr (in Cr) | Rev QoQ (in %) | Rev 1Y change % | Rev 3Y change % | Profit Mar Qtr | Profit Mar QoQ | Profit Mar 1Y Change% | Profit Mar 3Y Change% | Sector | M Cap | ROE | ROCE | EPS | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adani Power Ltd | ₹567.40 | LARGE CAP | 21.15% | 44.79% | 433.84% | 813.89% | 18.57 | 28.44 | 6.88 | 1.74 | 3297.52 Cr | 94.18% | 1540.09% | 13338.88 | 29.86% | 92.02% | 41.37% | 49.53% | 754.11% | Utilities | 223297.48 | 55.41% | 30.81% | 54 | 1243813 | |||
Tata Motors Ltd | ₹788.35 | LARGE CAP | 23.13% | 58.7% | 371.69% | 9.15 | 36.59 | 12.63 | 1.09 | 3450 Cr | 1082.46% | 100534 | 26.58% | 75.32% | 7.26% | 834.16% | Consumer Cyclical | 296209.41 | 19.5% | 14.69% | 82.99 | 27587619 | ||||||
Adani Wilmar Ltd | ₹332.80 | MID CAP | 10.31% | 22.22% | 22.22% | 43.37 | 139.55 | 5.04 | 0.99 | 281.91 Cr | 14460.45 | 2.06% | 38.21% | 0.33% | Edible Oil | 42609.96 | 3.42% | 9.6% | 1.31 | 873339 | ||||||||
Infosys Ltd | ₹1,872.35 | LARGE CAP | 10.35% | 33.99% | 4.49% | 169.05% | 28.57 | 39.06 | 7.66 | 0.74 | 6516 Cr | 2.23% | 8.88% | 35.14% | 40986 | 4.25% | 4.7% | 52.95% | 17.08% | 3.99% | Technology | 772343.15 | 36.58% | 45.07% | 63.37 | 3804234 | ||
Tata Steel Ltd | ₹145.09 | LARGE CAP | 19.99% | 12.65% | 264.44% | 61.71 | 25.07 | 1.43 | 1.47 | 758.84 Cr | 53489.73 | 46.63% | Industrials | 181023.63 | 7.79% | 13.67% | 47497863 | |||||||||||
Yes Bank Ltd | ₹19.94 | MID CAP | 8.1% | 51.25% | 33.71 | 15.69 | 1.62 | 1.28 | 566.59 Cr | 9.8% | 74.66% | 9225.45 | 2.55% | 23.98% | 42.4% | 3.9% | 7.08% | 40.88% | Financial Services | 62351.97 | 2.45% | NA | 0.45 | 81817209 | ||||
Zomato Ltd | ₹258.44 | LARGE CAP | 86.19% | 109.83% | 69.03% | 105.25% | 304.26 | 6.95 | 0.72 | 176 Cr | 4799 | 14.1% | 71.13% | 507.58% | 2.9% | Technology | 228525.48 | 5.15% | 5.18% | 0.4 | 43972581 | |||||||
ITC Ltd | ₹475.70 | LARGE CAP | 8.78% | 104.79% | 87.89% | 28.99 | 29.84 | 7.41 | 0.61 | 5054.43 Cr | 6.54% | 55.06% | 20581.57 | 12.22% | 43.85% | 29.28% | 6.63% | 7.79% | Consumer Defensive | 596649.78 | 29.21% | 37.4% | 16.62 | 5488948 | ||||
Wipro Ltd | ₹573.70 | LARGE CAP | 26.31% | 49.95% | 126.59% | 25.51 | 39.06 | 4.34 | 1.08 | 3226.6 Cr | 6.26% | 2.25% | 22301.6 | 1.54% | 44.93% | 12.38% | 4.65% | Technology | 300033.48 | 15.13% | 19.03% | 21.27 | 8069722 | |||||
HDFC Bank Ltd | ₹1,721.50 | LARGE CAP | 17.75% | 13.73% | 40.46% | 19.41 | 15.69 | 2.5 | 0.98 | 17825.91 Cr | 8.2% | 39.27% | 101.24% | 121456.74 | 3.81% | 99.35% | 161.73% | 15.7% | 4.23% | Financial Services | 1349733.6 | 16.88% | NA | 86.15 | 12282681 |
Pharma stocks represent publicly traded companies involved in researching, developing, manufacturing, and marketing pharmaceutical drugs and treatments. These companies play a vital role in advancing healthcare and stand to benefit from successful product launches and growing healthcare needs.
Diversification is crucial when investing in pharmaceutical sector stocks. While the industry presents significant growth opportunities, it also entails considerable risks and uncertainties, including patent expirations, regulatory hurdles, and potential clinical trial failures, among others.
By spreading investments across multiple pharmaceutical companies, investors can mitigate risk and lessen the potential negative impact on overall returns. This approach allows for a balance between potential gains and losses, ultimately improving the performance and stability of returns.
Government policy changes can have a significant impact on pharmaceutical sector stocks. In particular, government decisions related to reimbursement rates, intellectual property rights, and drug pricing can greatly influence the market potential and profitability of pharmaceutical companies.
Penny Stocks | Nifty 50 Stocks | Railway Stocks | Ethanol Stocks | Green Energy Stocks | Solar Energy Stocks | Semiconductor Stocks | AI Stocks | Indices | Government & PSU Stocks | Multibagger Stocks | Dividend Stocks | EV Stocks | Sugar Stocks | Blue Chip Stocks | Bonus Shares | Defence Stocks | Large Cap Stocks | Mid Cap Stocks | Small Cap Stocks | Green Hydrogen Stocks | Infrastructure Stocks | Undervalued Stocks | Upper Circuit Stocks | Lower Circuit Stocks | Sensex Stocks | FMCG Stocks | Intraday Stocks | Pharma Stocks | Chemical Stocks | IT Stocks | Most Active Stocks
INDmoney is 100% Safe and Secure!
Your security and privacy are our top priority!
27001:2022
ISO Certified
Audited by
cert-in empanelled auditors
AES 256-BIT
SSL Secured
Your personal information is protected.
With AES 256-bit encryption and TLS 1.3 secure data in transit.